Boryung to build W20 billion cGMP plant

Boryung Pharm said on August 14 it will invest 20 billion won to build a new cGMP plant producing the raw materials of fimasartan, a novel, non-peptide angiotensin II receptor antagonist and other finished products.

The plant will be built on some 6,863 square meters of land in Ansan of Kyunggi Province and its production capacity for pharmaceutical raw materials will reach 47.5 tons per yea...